<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Syst. Neurosci.</journal-id>
<journal-title>Frontiers in Systems Neuroscience</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Syst. Neurosci.</abbrev-journal-title>
<issn pub-type="epub">1662-5137</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fnsys.2014.00195</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Neuroscience</subject>
<subj-group>
<subject>Perspective Article</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Cognitive biases can affect moral intuitions about cognitive enhancement</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>Caviola</surname> <given-names>Lucius</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="author-notes" rid="fn001"><sup>&#x0002A;</sup></xref>
<uri xlink:href="http://community.frontiersin.org/people/u/108702"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Mannino</surname> <given-names>Adriano</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<uri xlink:href="http://community.frontiersin.org/people/u/186575"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Savulescu</surname> <given-names>Julian</given-names></name>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<xref ref-type="aff" rid="aff4"><sup>4</sup></xref>
<uri xlink:href="http://community.frontiersin.org/people/u/169105"/>
</contrib> 
<contrib contrib-type="author" corresp="yes">
<name><surname>Faulm&#x000FC;ller</surname> <given-names>Nadira</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff4"><sup>4</sup></xref>
<xref ref-type="aff" rid="aff5"><sup>5</sup></xref>
<xref ref-type="author-notes" rid="fn001"><sup>&#x0002A;</sup></xref>
<uri xlink:href="http://community.frontiersin.org/people/u/108674"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Department of Experimental Psychology, University of Oxford</institution> <country>Oxford, UK</country></aff>
<aff id="aff2"><sup>2</sup><institution>Department of Philosophy, University of Bern</institution> <country>Bern, Switzerland</country></aff>
<aff id="aff3"><sup>3</sup><institution>Oxford Uehiro Centre for Practical Ethics, University of Oxford</institution> <country>Oxford, UK</country></aff>
<aff id="aff4"><sup>4</sup><institution>Oxford Centre for Neuroethics, University of Oxford</institution> <country>Oxford, UK</country></aff>
<aff id="aff5"><sup>5</sup><institution>Department Values, Technology and Innovation, Delft University of Technology</institution> <country>Delft, Netherlands</country></aff>
<author-notes>
<fn fn-type="edited-by"><p>Edited by: Mikhail Lebedev, Duke University, USA</p></fn>
<fn fn-type="edited-by"><p>Reviewed by: Peter B. Reiner, University of British Columbia, Canada; Ioan Opris, Wake Forest University, USA; Nick J. Davis, Swansea University, UK</p></fn>
<fn fn-type="corresp" id="fn001"><p>&#x0002A;Correspondence: Lucius Caviola and Nadira Faulm&#x000FC;ller, Department of Experimental Psychology, University of Oxford, 9 South Parks Road, Oxford, OX1 3UD, UK e-mail: <email>lucius.caviola&#x00040;psy.ox.ac.uk</email>; <email>nadira.faulmueller&#x00040;psy.ox.ac.uk</email></p></fn>
<fn fn-type="other" id="fn002"><p>This article was submitted to the journal Frontiers in Systems Neuroscience.</p></fn>
</author-notes>
<pub-date pub-type="epub">
<day>15</day>
<month>10</month>
<year>2014</year>
</pub-date>
<pub-date pub-type="collection">
<year>2014</year>
</pub-date>
<volume>8</volume>
<elocation-id>195</elocation-id>
<history>
<date date-type="received">
<day>31</day>
<month>05</month>
<year>2014</year>
</date>
<date date-type="accepted">
<day>22</day>
<month>09</month>
<year>2014</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2014 Caviola, Mannino, Savulescu and Faulm&#x000FC;ller.</copyright-statement>
<copyright-year>2014</copyright-year>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution and reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract><p>Research into cognitive biases that impair human judgment has mostly been applied to the area of economic decision-making. Ethical decision-making has been comparatively neglected. Since ethical decisions often involve very high individual as well as collective stakes, analyzing how cognitive biases affect them can be expected to yield important results. In this theoretical article, we consider the ethical debate about cognitive enhancement (CE) and suggest a number of cognitive biases that are likely to affect moral intuitions and judgments about CE: status quo bias, loss aversion, risk aversion, omission bias, scope insensitivity, nature bias, and optimistic bias. We find that there are more well-documented biases that are likely to cause irrational aversion to CE than biases in the opposite direction. This suggests that common attitudes about CE are predominantly negatively biased. Within this new perspective, we hope that subsequent research will be able to elaborate this hypothesis and develop effective de-biasing techniques that can help increase the rationality of the public CE debate and thus improve our ethical decision-making.</p></abstract>
<kwd-group>
<kwd>cognitive enhancement</kwd>
<kwd>rationality</kwd>
<kwd>cognitive bias</kwd>
<kwd>attitudes</kwd>
<kwd>de-biasing</kwd>
<kwd>moral intuitions</kwd>
<kwd>brain function augmentation</kwd>
</kwd-group>
<counts>
<fig-count count="0"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="57"/>
<page-count count="0"/>
<word-count count="5009"/>
</counts>
</article-meta>
</front>
<body>
<sec id="s1">
<title>Cognitive enhancement and biased reasoning</title>
<p>The enhancement of cognitive brain functions by means of technology has become a reality. Recent research has demonstrated that various pharmaceuticals can have&#x02014;at least modest&#x02014;performance-enhancing effects in healthy individuals (for reviews, see Repantis et al., <xref ref-type="bibr" rid="B42">2010</xref>; Husain and Mehta, <xref ref-type="bibr" rid="B29">2011</xref>). In line with these findings, the off-label use of pharmacological substances like methylphenidate (e.g., Ritalin-<sup>&#x000AE;</sup>) or modafinil (e.g., Provigil-<sup>&#x000AE;</sup>) seems to be prevalent, in particular among students (Herman-Stahl et al., <xref ref-type="bibr" rid="B28">2007</xref>; Smith and Farah, <xref ref-type="bibr" rid="B50">2011</xref>; Dietz et al., <xref ref-type="bibr" rid="B14">2013</xref>), and professionals in very responsible jobs like physicians (Franke et al., <xref ref-type="bibr" rid="B22">2013</xref>). It has even been argued that the use of such substances might become an implicit requirement for individuals in certain professions (e.g., <xref ref-type="bibr" rid="B40">Maslen et al., in press</xref>). Non-pharmacological methods of cognitive enhancement (CE), such as gene therapy or neural implants, could become more widely used in the future (Bostrom and Sandberg, <xref ref-type="bibr" rid="B8">2009</xref>). Even though there is considerable use of CE, recent research shows that the general public has strongly negative attitudes regarding the introduction and use of CE (for a review, see Schelle et al., <xref ref-type="bibr" rid="B48">2014</xref>).</p>
<p>In this article, we argue that these concerns are partly driven by pervasive cognitive biases. A bias is a systematic deviation from a standard of rationality (Baron, <xref ref-type="bibr" rid="B2">2005</xref>), an error frequently committed by the human mind. We use the definition of &#x0201C;rationality&#x0201D; common in cognitive science, referring to normative models of accurate belief formation (Foley, <xref ref-type="bibr" rid="B19">1987</xref>; Audi, <xref ref-type="bibr" rid="B1">2001</xref>) and optimal decision-making in order to achieve one&#x02019;s goal (Dawes, <xref ref-type="bibr" rid="B12">1998</xref>). (Ir)rationality is therefore relative to the goal of having accurate beliefs or to goals in general. Thus, while some cognitive patterns may be suboptimal with regard to a particular goal, they may be perfectly optimal with regard to another. For illustration, consider &#x0201C;status quo bias&#x0201D;, which we will address in the following section. If, upon reflection, an agent consciously and stably places some intrinsic value on the status quo, then in no sense can the agent be said to irrationally prefer the status quo (i.e., to make a cognitive mistake in doing so). However, the available evidence suggests that human agents do not, upon reflection, intrinsically care about the status quo, or at least to a significantly lesser degree than their immediate intuitions would have it: the experiments documenting our intuitive status quo preference (e.g., Samuelson and Zeckhauser, <xref ref-type="bibr" rid="B44">1988</xref>) are interesting because they reveal a fact about our intuitive decision-making which our reflection disapproves of and is thus irrational. Also, nearly all action-guiding moral theories have an account of when the status quo should be modified, which is why the general bias towards it will tend to bring about suboptimal moral outcomes (c.f. Bostrom and Ord, <xref ref-type="bibr" rid="B7">2006</xref>). Furthermore, if by &#x0201C;moral&#x0201D; decision-making we mean decision-making that is optimal from an &#x0201C;altruist&#x0201D; or &#x0201C;impartial&#x0201D; perspective, then non-related goals such as status quo preservation will lead to irrationality, too. Hence, it is justifiable to classify the status quo bias and the other biases we are discussing below as, indeed, biases.</p>
<p>The aim of this paper is to offer a new perspective on the debate about CE by identifying cognitive biases that affect our common intuitions and moral reactions. We will first give a rough overview of the academic debate and the public&#x02019;s view of CE and then discuss a number of potential biases that are likely to influence widespread judgments about CE.</p>
<p>In the academic debate about CE, opinions of critics (often bioconservatives) and supporters (often transhumanists) are quite sharply divided. Critics often question its medical safety, considering the potential side effects and unknown long-term health risks (Healey and Rayner, <xref ref-type="bibr" rid="B27">2008</xref>). Critics also see CE as a threat to human autonomy (Habermas, <xref ref-type="bibr" rid="B25">2003</xref>), authenticity (Elliott, <xref ref-type="bibr" rid="B15">2004</xref>) humility and solidarity (Sandel, <xref ref-type="bibr" rid="B45">2004</xref>) and equality and fairness (Fukuyama, <xref ref-type="bibr" rid="B23">2004</xref>). Proponents, on the other hand, focus on the potential positive aspects and potentials of CE. For instance, Savulescu (<xref ref-type="bibr" rid="B46">2006</xref>) points out that the introduction of CE could help decrease unfair natural differences in abilities. Bostrom (<xref ref-type="bibr" rid="B6">2008</xref>) emphasizes the enormous positive leverage effect that CE could generate in the future. He speculates that a 1% increase in all scientists&#x02019; cognitive performance &#x0201C;would amount to an indirect contribution equal to 100,000 times what the average scientist contributes&#x0201D; (p. 2). Others note that CE is not relevantly different from traditional forms of enhancement, such as information technology (Harris, <xref ref-type="bibr" rid="B26">2010</xref>).</p>
<p>Recent research reviewing the general public&#x02019;s attitudes towards CE has shown that lay people share many of the critics&#x02019; concerns about CE (Schelle et al., <xref ref-type="bibr" rid="B48">2014</xref>). Participants from samples of students or parents, for example, fear that safety is not ensured (Forlini and Racine, <xref ref-type="bibr" rid="B21">2012</xref>; Partridge et al., <xref ref-type="bibr" rid="B41">2013</xref>). They think that CE could lead to peer pressure and thus undermine our autonomous decisions (Forlini and Racine, <xref ref-type="bibr" rid="B20">2009</xref>). Also, they worry that unequal distribution of CE would result in an unfair advantage of a privileged few (Fitz et al., <xref ref-type="bibr" rid="B18">2013</xref>). These views are often reflected in exaggerated reports by the media and might even lead to severe aversive social consequences for users (Faulm&#x000FC;ller et al., <xref ref-type="bibr" rid="B16">2013</xref>). The Guardian, for example, has described CE substances as &#x0201C;capitalism&#x02019;s wonder-pills&#x0201D;, which &#x0201C;turn you into the closest human approximation there is to a machine&#x0201D; (Mahdawi, <xref ref-type="bibr" rid="B38">2012</xref>).</p>
<p>We believe that the common concerns about CE are justified at least to some extent, and a greater scientific understanding of CE is required in order to draw confident conclusions (Maslen et al., <xref ref-type="bibr" rid="B39">2014</xref>). Most importantly, long-term safety of CE is not currently ensured (c.f. Husain and Mehta, <xref ref-type="bibr" rid="B29">2011</xref>) and is being called into question (e.g., Urban and Gao, <xref ref-type="bibr" rid="B55">2014</xref>). Nevertheless, we speculate that the public&#x02019;s views on CE are negatively biased. While the involved biases do not necessarily undermine any specific argument for or against CE&#x02014;these would need to be evaluated on their philosophical and scientific merits&#x02014;they might partially explain the general opposition to CE as well as the selective focus on certain arguments and exaggeration of their relative weight. It is not unusual for human cognition to selectively search for certain classes of arguments and systematically neglect or undervalue certain others (c.f. Kunda, <xref ref-type="bibr" rid="B36">1990</xref> on &#x0201C;motivated reasoning&#x0201D;)&#x02014;a bias that might affect the judgments of both opponents and proponents of CE. Biases may lead people to come up with a set of arguments that expresses sound considerations but is significantly incomplete or weighted wrongly. We thus propose that in order to fully explain prevalent opposition to CE, it is necessary to look into the role biases play in the CE context. Awareness of these biases is a precondition of rational public debate about CE, which in turn is needed for developing and establishing optimal social and legal regulations.</p>
<p>Empirical research into biases over the last four decades has shown that human reasoning is very prone to systematic irrational patterns, i.e., cognitive biases (e.g., Tversky and Kahneman, <xref ref-type="bibr" rid="B54">1974</xref>), especially when the subject matter is as complex, novel, abstract and ideologically loaded as is the use and regulation of CE (Cosmides and Tooby, <xref ref-type="bibr" rid="B10">1992</xref>; Kahan et al., <xref ref-type="bibr" rid="B30">2013</xref>). We argue that a number of cognitive biases well-documented in psychology and behavioral economics partly explain prevalent negative attitudes towards CE. While we believe that attitudes towards CE are predominantly negatively biased, there may also be biases leading us to irrationally favor CE. We will indicate some biases likely to affect judgments about CE and illustrate why and how they may be impairing our judgments in this context. Thus, our aim is to suggest several hypotheses about potential irrational sources of the prevalent (negative or positive) attitudes towards CE. Some of the biases on our below list have been studied in behavioral economics, such as status quo bias, loss aversion, risk aversion, scope insensitivity. The others&#x02014;omission bias, nature bias, and optimistic bias&#x02014;have been addressed more in psychology and philosophy. Our application of the knowledge about biases to the CE debate is comparatively novel, as is the application to ethical issues in general. We hope to offer a valuable perspective as a contribution to more rational public debate on controversial ethical issues involving new practices or technologies. Since ethical questions often involve high stakes, this endeavor can be expected to yield important results for public ethical debate.</p>
</sec>
<sec id="s2">
<title>Potential cognitive biases</title>
<sec id="s2-1">
<title>Status quo bias</title>
<p>Status quo bias describes the tendency to prefer the current state of affairs over a change even if a change would result in better expected outcomes. For instance, Samuelson and Zeckhauser (<xref ref-type="bibr" rid="B44">1988</xref>) presented participants with hypothetical choice tasks about financial investment, which either were defined with a clear status quo or not. Participants were significantly more likely to choose the option designated as the status quo compared to the same option that was not labeled the status quo. Numerous further experiments reliably demonstrate this effect (e.g., Kahneman et al., <xref ref-type="bibr" rid="B33">1991</xref>). It seems plausible that popular aversion to CE is partly due to status quo bias: it may partly result from the pure fact that CE constitutes a novelty. Historically, new ideas and technologies have often encountered strong aversion and opposition at first (Jay, <xref ref-type="bibr" rid="B59">1981</xref>; Weil and Rosen, <xref ref-type="bibr" rid="B56">1995</xref>), but became accepted at a later point in time. Coffee&#x02014;a traditional form of CE&#x02014;provides an instructive example: it was first considered an unacceptable drug and even forbidden in some countries (Weinberg and Bealer, <xref ref-type="bibr" rid="B57">2001</xref>; Cowan, <xref ref-type="bibr" rid="B11">2005</xref>). Bostrom and Ord (<xref ref-type="bibr" rid="B7">2006</xref>) have already drawn attention to the role status quo bias likely plays in the debate about CE. They also suggest a de-biasing tool&#x02014;the <italic>Reversal Test</italic>&#x02014;designed to expose and overcome status quo bias. If we believe that the enhancement of certain cognitive abilities will have negative consequences, we should consider the reverse: if an increase in intelligence is judged as negative, would a decrease in intelligence be judged favorable? If not, we are committed to claiming that our current level of intelligence is at an at least local optimum. This is, of course, possible but would require further justification. Obviously, it is an empirical question whether the introduction of CE actually results in net positive consequences or not. In case it would, however, status quo bias still exerts a psychological force against its endorsement. Empirical research can potentially expose the prevalence of status quo bias by, for example, observing whether people come to a different conclusion after reflecting on the rationale of the Reversal Test and applying it to the context of CE.</p>
</sec>
<sec id="s2-2">
<title>Loss aversion</title>
<p>Loss aversion describes the tendency to weigh losses more than gains (Kahneman and Tversky, <xref ref-type="bibr" rid="B34">1984</xref>). In monetary contexts, for example, loss aversion results in a stronger dissatisfaction after losing $1 than satisfaction after gaining $1 (Kahneman and Tversky, <xref ref-type="bibr" rid="B34">1984</xref>). Whether something is perceived as a loss or as a gain depends on how the decisional situation is framed: one can either &#x0201C;get a $1 discount&#x0201D; or &#x0201C;avoid a $1 surcharge&#x0201D;. Loss aversion can act on its own, but may also be a source of status quo bias (Bostrom and Ord, <xref ref-type="bibr" rid="B7">2006</xref>). Maybe we recognize positive as well as negative consequences that the introduction of CE likely entails, such as the potential benefits due to enhanced intelligence on the one hand and the fear of increased unfairness in society due to unequal access to CE on the other hand (Fitz et al., <xref ref-type="bibr" rid="B18">2013</xref>). But due to loss aversion, we likely tend to exaggerate the weight of the negative consequences relative to the positive ones.</p>
</sec>
<sec id="s2-3">
<title>Risk aversion</title>
<p>Risk aversion describes the tendency to undervalue an option that is less certain compared to a more certain option with equal expected outcome value (Kahneman and Tversky, <xref ref-type="bibr" rid="B34">1984</xref>). Since preserving the status quo usually involves less uncertainty than a change does, risk aversion may be a further source of status quo bias, and it can act on its own as well. Consider a gamble where you have the option A of winning $1000 with a chance of 85% or the option B of winning $800 for sure. Most people prefer option B to A. However, option A has a higher expected value of 0.85 <sup>*</sup> $1000 = $850 and is therefore the rational decision if one values money linearly. As we are constantly faced with uncertainty, we are in fact dealing with such gambles all the time. We may be reluctant to introduce CE simply because its expected consequences involve probabilities that deviate more strongly from 100% and 0% than do the ones of the status quo. For example, methylphenidate almost certainly improves memory (for a meta-analysis, see Repantis et al., <xref ref-type="bibr" rid="B42">2010</xref>), but there is a chance of long-term adverse effects (King et al., <xref ref-type="bibr" rid="B35">2006</xref>). Though the expected utility calculation may favor the use of methylphenidate in certain cases, people are likely to retain a preference against it due to risk aversion and a resulting &#x0201C;precautionary principle&#x0201D; heuristic.</p>
</sec>
<sec id="s2-4">
<title>Omission bias</title>
<p>Omission bias describes the tendency to judge decisions differently depending on whether the same outcome is brought about through an act or an omission (Spranca et al., <xref ref-type="bibr" rid="B51">1991</xref>). More specifically, people consider harms that have been caused by action worse than equal harms caused by omission. Ritov and Baron (<xref ref-type="bibr" rid="B43">1990</xref>) observed that parents often show reluctance to vaccinate their children. The expected harm of non-prevented disease is much greater than the expected harm of vaccination (Gangarosa et al., <xref ref-type="bibr" rid="B24">1998</xref>), but parents seem to overvalue the expected harm caused by the vaccination because it is the result of their action. Similarly, we may fear that the introduction of CE is likely to or may cause harm. However, CE may also prevent harms from occurring and thus refraining from introducing may be a harmful omission, i.e., a missed opportunity for reducing harm. Due to our general omission bias, we are likely to systematically overvalue the harm of introducing CE compared to the harm resulting from not introducing it. For example, people might believe that the use of CE substances by medical doctors potentially causes active harm by inducing sleep disorders (Partridge et al., <xref ref-type="bibr" rid="B41">2013</xref>)&#x02014;but they might neglect or underestimate the potential positive consequences of doctors&#x02019; increased ability to focus, i.e., the potential negative consequences of inaction. Rejecting CE may lead to greater harms suffered by more people overall. This question cannot be settled by unreflective intuition but requires open&#x02014;un-biased&#x02014;scientific investigation.</p>
</sec>
<sec id="s2-5">
<title>Scope insensitivity</title>
<p>Scope insensitivity occurs when people don&#x02019;t assign appropriate weight to the quantity of a decisional option (Kahneman, <xref ref-type="bibr" rid="B31">2000</xref>; Desvousges et al., <xref ref-type="bibr" rid="B13">2010</xref>). For example, a study has demonstrated that people are willing to pay the same amount of money to either help 9,000 people or 90,000 people who are at risk (Kahneman and Knetsch, <xref ref-type="bibr" rid="B32">1992</xref>; Baron and Greene, <xref ref-type="bibr" rid="B3">1996</xref>). This is irrational if one&#x02019;s goal is to help people and have everyone count the same, for the money one is willing to pay should then scale linearly with the number of people affected. It seems that our ability to intuitively represent such large numbers and their relations correctly is quite limited. In the context of CE, a probable implication is that we are not giving appropriate weight to the enormously high number of individual decisions, people (and generations) potentially affected by the consequences of introducing CE and thus to the importance and priority of the CE issue.</p>
</sec>
<sec id="s2-6">
<title>Nature bias</title>
<p>Several studies on peoples&#x02019; attitudes towards CE have revealed that natural CE substances are seen as less harmful and less ethically problematic than artificial ones (e.g., Bergstr&#x000F6;m and Lyn&#x000F6;e, <xref ref-type="bibr" rid="B4">2008</xref>). For example, in a study with university students, participants were more likely to consider the use of artificial CE substances morally wrong than herbal ones (Scheske and Schnall, <xref ref-type="bibr" rid="B49">2012</xref>). These judgments seem to be impaired by a form of nature bias (c.f. the fallacy of <italic>appealing to nature</italic>), i.e., a tendency to view the &#x0201C;natural&#x0201D; as good and the &#x0201C;unnatural&#x0201D; as bad. Given that many examples of &#x0201C;natural and bad&#x0201D; (e.g., diseases) as well as &#x0201C;unnatural and good&#x0201D; (e.g., medicine) things exist, it is highly questionable whether tracking the &#x0201C;natural&#x0201D; tracks what people (would) actually assign value to, and it is clear that it is not intrinsically morally relevant according to the &#x0201C;altruistically/impartially optimal decision-making&#x0201D; criterion.</p>
</sec>
<sec id="s2-7">
<title>Optimistic bias</title>
<p>Some biases may also be pushing people towards an overly optimistic evaluation of the consequences of introducing CE. An example is the optimistic bias described by Chapin and Coleman (<xref ref-type="bibr" rid="B9">2009</xref>), which causes people to underestimate the possibility of negative outcomes. Examples include people underestimating the risk of becoming a victim of crime, of losing money in the markets, or of getting lung cancer after smoking (Weinstein and Klein, <xref ref-type="bibr" rid="B58">1996</xref>). In the context of CE, people might underestimate the dangers, such as negative side effects, that CE could entail.</p>
<p>An additional source of optimistically skewed views of CE might result from biased reduction of cognitive dissonance by people who are already using forms of CE. When confronted with falsificatory information about CE, such as documented health concerns, users might experience discomfort&#x02014;cognitive dissonance&#x02014;and be likely to selectively adopt beliefs that justify their behavior (Festinger, <xref ref-type="bibr" rid="B17">1957</xref>).</p>
<p>Thus, there are potential biases leading to an overly positive attitude towards CE. Overall, however, it seems there are more well-documented highly prevalent biases likely to cause irrational aversion to CE than biases in the opposite direction.</p>
</sec>
</sec>
<sec sec-type="conclusion" id="s3">
<title>Conclusion</title>
<p>We have aimed to offer and motivate the perspective that biases are likely to impair judgments about CE, mostly in the negative direction. We are aware that the above list of biases is incomplete and speculative and hope that empirical research will further elaborate on our suggestions. It must be emphasized that &#x0201C;biases&#x0201D; often do provide sensible decisional rules of thumb&#x02014;after all, many of them seem to have proven to be successful heuristics for our evolutionary ancestors. However, the practical scope of this argument is very limited first because our current environment is different from our evolutionary environment, and second because the metaphorical goals of our genes that have been served by some &#x0201C;bias-heuristics&#x0201D; need not coincide with our goals (Stanovich, <xref ref-type="bibr" rid="B52">2004</xref>). Nevertheless, the existence of such biases cannot alone undermine the soundness of any objection to CE. But they can explain why people, including policy makers, may take an unreflective or one-sided position on such debates. More generally, many of our moral intuitions about controversial practices are likely to be influenced by such cognitive biases. Not only do we require psychological interventions such as remedial heuristics, we require good ethical argument and relevant scientific evidence to identify which of our moral intuitions are justified, and which are not.</p>
<p>We believe the CE debate would benefit from research investigating the role cognitive biases play in judgments about CE and from the subsequent development of techniques that help people judge the relevant issues in a less biased way. These techniques should be simple heuristics (Larrick, <xref ref-type="bibr" rid="B37">2004</xref>) that are easily applicable in the context of CE. Bostrom and Ord (<xref ref-type="bibr" rid="B7">2006</xref>) <italic>Reversal Test</italic> or Savulescu (<xref ref-type="bibr" rid="B47">2007</xref>) <italic>Loss/Gain Heuristic</italic> are examples of such heuristics. Psychological research could test whether people&#x02019;s attitudes towards CE change after applying de-biasing techniques, i.e., by being made aware of the biases potentially impairing their judgments. If they do change, we have reason to assume that cognitive biases play a role in the current attitudes towards CE.</p>
</sec>
<sec id="s4">
<title>Conflict of interest statement</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</body>
<back>
<ack>
<p>This work was supported by the Wellcome Trust (grant code 086041/Z/08/Z) and the Oxford Martin School (Oxford Martin Programme on Resource Stewardship), supporting Julian Savulescu and Nadira Faulm&#x000FC;ller. This work was supervised by Nadira Faulm&#x000FC;ller.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="B1"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Audi</surname> <given-names>R.</given-names></name></person-group> (<year>2001</year>). <source>The Architecture of Reason: The Structure and Substance of Rationality.</source> <publisher-loc>New York, NY</publisher-loc>: <publisher-name>Oxford University Press</publisher-name>.</citation></ref>
<ref id="B2"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Baron</surname> <given-names>J.</given-names></name></person-group> (<year>2005</year>). <source>Thinking and Deciding.</source> <publisher-loc>Cambridge, MA</publisher-loc>: <publisher-name>Cambridge University Press</publisher-name>.</citation></ref>
<ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Baron</surname> <given-names>J.</given-names></name> <name><surname>Greene</surname> <given-names>J.</given-names></name></person-group> (<year>1996</year>). <article-title>Determinants of insensitivity to quantity in valuation of public goods: contribution, warm glow, budget constraints, availability and prominence</article-title>. <source>J. Exp. Psychol. Appl.</source> <volume>2</volume>, <fpage>107</fpage>&#x02013;<lpage>125</lpage>. <pub-id pub-id-type="doi">10.1037/1076-898x.2.2.107</pub-id></citation></ref>
<ref id="B4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bergstr&#x000F6;m</surname> <given-names>L. S.</given-names></name> <name><surname>Lyn&#x000F6;e</surname> <given-names>N.</given-names></name></person-group> (<year>2008</year>). <article-title>Enhancing concentration, mood and memory in healthy individuals: an empirical study of attitudes among general practitioners and the general population</article-title>. <source>Scand. J. Public Health</source> <volume>36</volume>, <fpage>532</fpage>&#x02013;<lpage>537</lpage>. <pub-id pub-id-type="doi">10.1177/1403494807087558</pub-id><pub-id pub-id-type="pmid">18635734</pub-id></citation></ref>
<ref id="B6"><citation citation-type="web"><person-group person-group-type="author"><name><surname>Bostrom</surname> <given-names>N.</given-names></name></person-group> (<year>2008</year>). &#x0201C;<article-title>Three ways to advance science</article-title>,&#x0201D; in <source>Nature Podcast</source>. Available online at: <ext-link ext-link-type="uri" xlink:href="http://www.nickbostrom.com/views/science.pdf">http://www.nickbostrom.com/views/science.pdf</ext-link>. Accessed on January 31, 2008.</citation></ref>
<ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bostrom</surname> <given-names>N.</given-names></name> <name><surname>Ord</surname> <given-names>T.</given-names></name></person-group> (<year>2006</year>). <article-title>The reversal test: eliminating status quo bias in applied ethics</article-title>. <source>Ethics</source> <volume>116</volume>, <fpage>656</fpage>&#x02013;<lpage>679</lpage>. <pub-id pub-id-type="doi">10.1086/505233</pub-id><pub-id pub-id-type="pmid">17039628</pub-id></citation></ref>
<ref id="B8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bostrom</surname> <given-names>N.</given-names></name> <name><surname>Sandberg</surname> <given-names>A.</given-names></name></person-group> (<year>2009</year>). <article-title>Cognitive enhancement: methods, ethics, regulatory challenges</article-title>. <source>Sci. Eng. Ethics</source> <volume>15</volume>, <fpage>311</fpage>&#x02013;<lpage>341</lpage>. <pub-id pub-id-type="doi">10.1007/s11948-009-9142-5</pub-id><pub-id pub-id-type="pmid">19543814</pub-id></citation></ref>
<ref id="B9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chapin</surname> <given-names>J.</given-names></name> <name><surname>Coleman</surname> <given-names>G.</given-names></name></person-group> (<year>2009</year>). <article-title>Optimistic bias: what you think, what you know, or whom you know?. </article-title> <source>N. Am. J. Psychol.</source> <volume>11</volume>, <fpage>121</fpage>&#x02013;<lpage>132</lpage>. Available online at: <ext-link ext-link-type="uri" xlink:href="http://www.questia.com/library/journal/1G1-195427665/optimistic-bias-what-you-think-what-you-know-or">http://www.questia.com/library/journal/1G1-195427665/optimistic-bias-what-you-think-what-you-know-or</ext-link> </citation></ref>
<ref id="B10"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Cosmides</surname> <given-names>L.</given-names></name> <name><surname>Tooby</surname> <given-names>J.</given-names></name></person-group> (<year>1992</year>). &#x0201C;<article-title>Cognitive adaptations for social exchange</article-title>,&#x0201D; in <source>The Adapted Mind: Evolutionary Psychology and the Generation of Culture</source>, eds <person-group person-group-type="editor"><name><surname>Barkow</surname> <given-names>J.</given-names></name> <name><surname>Cosmides</surname> <given-names>L.</given-names></name> <name><surname>Tooby</surname> <given-names>J.</given-names></name></person-group> (<publisher-loc>New York, NY</publisher-loc>: <publisher-name>Oxford University Press</publisher-name>), <fpage>163</fpage>&#x02013;<lpage>228</lpage>.</citation></ref>
<ref id="B11"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Cowan</surname> <given-names>B. W.</given-names></name></person-group> (<year>2005</year>). <source>The Social Life of Coffee: The Emergence of the British Coffee House.</source> <publisher-loc>New Haven, CT</publisher-loc>: <publisher-name>Yale University Press</publisher-name>.</citation></ref>
<ref id="B12"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Dawes</surname> <given-names>R. M.</given-names></name></person-group> (<year>1998</year>). &#x0201C;<article-title>Behavioral decision making and judgment</article-title>,&#x0201D; in <source>The Handbook of Social Psychology</source> (Vol. 1), eds <person-group person-group-type="editor"><name><surname>Gilbert</surname> <given-names>D. T.</given-names></name> <name><surname>Fiske</surname> <given-names>S. T.</given-names></name> <name><surname>Lindzey</surname> <given-names>G.</given-names></name></person-group> <edition>4th Edn.</edition> (<publisher-loc>Boston, MA</publisher-loc>: <publisher-name>McGraw-Hill</publisher-name>), <fpage>497</fpage>&#x02013;<lpage>548</lpage>.</citation></ref>
<ref id="B13"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Desvousges</surname> <given-names>W. H.</given-names></name> <name><surname>Johnson</surname> <given-names>F. R.</given-names></name> <name><surname>Dunford</surname> <given-names>R. W.</given-names></name> <name><surname>Boyle</surname> <given-names>K. J.</given-names></name> <name><surname>Hudson</surname> <given-names>S. P.</given-names></name> <name><surname>Wilson</surname> <given-names>K. N.</given-names></name> <etal/></person-group>. (<year>2010</year>). <source>Measuring Nonuse Damages Using Contingent Valuation: An Experimental Evaluation of Accuracy.</source> <edition>2nd Edn.</edition> <publisher-loc>Research Triangle Park, NC</publisher-loc>: <publisher-name>RTI Press</publisher-name>.</citation></ref>
<ref id="B14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dietz</surname> <given-names>P.</given-names></name> <name><surname>Striegel</surname> <given-names>H.</given-names></name> <name><surname>Franke</surname> <given-names>A. G.</given-names></name> <name><surname>Lieb</surname> <given-names>K.</given-names></name> <name><surname>Simon</surname> <given-names>P.</given-names></name> <name><surname>Ulrich</surname> <given-names>R.</given-names></name></person-group> (<year>2013</year>). <article-title>Randomized response estimates for the 12-month prevalence of cognitive-enhancing drug use in university students</article-title>. <source>Pharmacotherapy</source> <volume>33</volume>, <fpage>44</fpage>&#x02013;<lpage>50</lpage>. <pub-id pub-id-type="doi">10.1002/phar.1166</pub-id><pub-id pub-id-type="pmid">23307544</pub-id></citation></ref>
<ref id="B15"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Elliott</surname> <given-names>C.</given-names></name></person-group> (<year>2004</year>). <source>Better Than Well: American Medicine Meets the American Dream.</source> <publisher-loc>New York</publisher-loc>: <publisher-name>W. W. Norton and Company</publisher-name>.</citation></ref>
<ref id="B16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Faulm&#x000FC;ller</surname> <given-names>N.</given-names></name> <name><surname>Maslen</surname> <given-names>H.</given-names></name> <name><surname>Santoni de Sio</surname> <given-names>F.</given-names></name></person-group> (<year>2013</year>). <article-title>The indirect psychological costs of cognitive enhancement</article-title>. <source>Am. J. Bioeth.</source> <volume>13</volume>, <fpage>45</fpage>&#x02013;<lpage>47</lpage>. <pub-id pub-id-type="doi">10.1080/15265161.2013.794880</pub-id><pub-id pub-id-type="pmid">23767441</pub-id></citation></ref>
<ref id="B17"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Festinger</surname> <given-names>L.</given-names></name></person-group> (<year>1957</year>). <source>A Theory of Cognitive Dissonance.</source> <publisher-loc>Stanford, CA</publisher-loc>: <publisher-name>Stanford University Press</publisher-name>.</citation></ref>
<ref id="B18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fitz</surname> <given-names>N. S.</given-names></name> <name><surname>Nadler</surname> <given-names>R.</given-names></name> <name><surname>Manogaran</surname> <given-names>P.</given-names></name> <name><surname>Chong</surname> <given-names>E. W. J.</given-names></name> <name><surname>Reiner</surname> <given-names>P. B.</given-names></name></person-group> (<year>2013</year>). <article-title>Public attitudes toward cognitive enhancement</article-title>. <source>Neuroethics</source> <volume>7</volume>, <fpage>173</fpage>&#x02013;<lpage>188</lpage>. <pub-id pub-id-type="doi">10.1007/s12152-013-9190-z</pub-id></citation></ref>
<ref id="B19"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Foley</surname> <given-names>R.</given-names></name></person-group> (<year>1987</year>). <source>The Theory of Epistemic Rationality.</source> <publisher-loc>Cambridge, MA</publisher-loc>: <publisher-name>Harvard University Press</publisher-name>.</citation></ref>
<ref id="B20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Forlini</surname> <given-names>C.</given-names></name> <name><surname>Racine</surname> <given-names>E.</given-names></name></person-group> (<year>2009</year>). <article-title>Autonomy and coercion in academic &#x0201C;Cognitive Enhancement&#x0201D; using methylphenidate: perspectives of key stakeholders</article-title>. <source>Neuroethics</source> <volume>2</volume>, <fpage>163</fpage>&#x02013;<lpage>177</lpage>. <pub-id pub-id-type="doi">10.1007/s12152-009-9043-y</pub-id></citation></ref>
<ref id="B21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Forlini</surname> <given-names>C.</given-names></name> <name><surname>Racine</surname> <given-names>E.</given-names></name></person-group> (<year>2012</year>). <article-title>Stakeholder perspectives and reactions to &#x0201C;academic&#x0201D; cognitive enhancement: unsuspected meaning of ambivalence and analogies</article-title>. <source>Public Underst. Sci.</source> <volume>21</volume>, <fpage>606</fpage>&#x02013;<lpage>625</lpage>. <pub-id pub-id-type="doi">10.1177/0963662510385062</pub-id><pub-id pub-id-type="pmid">23823168</pub-id></citation></ref>
<ref id="B22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Franke</surname> <given-names>A. G.</given-names></name> <name><surname>Bagusat</surname> <given-names>C.</given-names></name> <name><surname>Dietz</surname> <given-names>P.</given-names></name> <name><surname>Hoffmann</surname> <given-names>I.</given-names></name> <name><surname>Simon</surname> <given-names>P.</given-names></name> <name><surname>Ulrich</surname> <given-names>R.</given-names></name> <etal/></person-group>. (<year>2013</year>). <article-title>Use of illicit and prescription drugs for cognitive or mood enhancement among surgeons</article-title>. <source>BMC Med. </source> <volume>11</volume>:<fpage>102</fpage>. <pub-id pub-id-type="doi">10.1186/1741-7015-11-102</pub-id><pub-id pub-id-type="pmid">24679209</pub-id></citation></ref>
<ref id="B23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fukuyama</surname> <given-names>F.</given-names></name></person-group> (<year>2004</year>). <article-title>Transhumanism</article-title>. <source>Foreign Policy</source> <volume>144</volume>, <fpage>42</fpage>&#x02013;<lpage>43</lpage>. <pub-id pub-id-type="doi">10.2307/4152980 </pub-id></citation></ref>
<ref id="B24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gangarosa</surname> <given-names>E. J.</given-names></name> <name><surname>Galazka</surname> <given-names>A. M.</given-names></name> <name><surname>Wolfe</surname> <given-names>C. R.</given-names></name> <name><surname>Phillips</surname> <given-names>L. M.</given-names></name> <name><surname>Gangarosa</surname> <given-names>R. E.</given-names></name> <name><surname>Miller</surname> <given-names>E.</given-names></name> <etal/></person-group>. (<year>1998</year>). <article-title>Impact of anti-vaccine movements on pertussis control: the untold story</article-title>. <source>Lancet</source> <volume>351</volume>, <fpage>356</fpage>&#x02013;<lpage>361</lpage>. <pub-id pub-id-type="doi">10.1016/s0140-6736(97)04334-1</pub-id><pub-id pub-id-type="pmid">9652634</pub-id></citation></ref>
<ref id="B25"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Habermas</surname> <given-names>J.</given-names></name></person-group> (<year>2003</year>). <source>The Future of Human Nature.</source> <publisher-loc>Cambridge, UK</publisher-loc>: <publisher-name>Polity Press</publisher-name>.</citation></ref>
<ref id="B26"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Harris</surname> <given-names>J.</given-names></name></person-group> (<year>2010</year>). <source>Enhancing Evolution: The Ethical Case for Making Better People.</source> <publisher-loc>Princeton</publisher-loc>: <publisher-name>Princeton University Press</publisher-name>.</citation></ref>
<ref id="B27"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Healey</surname> <given-names>P.</given-names></name> <name><surname>Rayner</surname> <given-names>S.</given-names></name></person-group> (<year>2008</year>). <source>Unnatural Selection: The Challenges of Engineering Tomorrow&#x02019;s People.</source> <publisher-loc>London</publisher-loc>: <publisher-name>Earthscan</publisher-name>.</citation></ref>
<ref id="B28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Herman-Stahl</surname> <given-names>M. A.</given-names></name> <name><surname>Krebs</surname> <given-names>C. P.</given-names></name> <name><surname>Kroutil</surname> <given-names>L. A.</given-names></name> <name><surname>Heller</surname> <given-names>D. C.</given-names></name></person-group> (<year>2007</year>). <article-title>Risk and protective factors for methamphetamine use and nonmedical use of prescription stimulants among young adults aged 18 to 25</article-title>. <source>Addict. Behav.</source> <volume>32</volume>, <fpage>1003</fpage>&#x02013;<lpage>1015</lpage>. <pub-id pub-id-type="doi">10.1016/j.addbeh.2006.07.010</pub-id><pub-id pub-id-type="pmid">16920275</pub-id></citation></ref>
<ref id="B29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Husain</surname> <given-names>M.</given-names></name> <name><surname>Mehta</surname> <given-names>M. A.</given-names></name></person-group> (<year>2011</year>). <article-title>Cognitive enhancement by drugs in health and disease</article-title>. <source>Trends Cogn. Sci.</source> <volume>15</volume>, <fpage>28</fpage>&#x02013;<lpage>36</lpage>. <pub-id pub-id-type="doi">10.1016/j.tics.2010.11.002</pub-id><pub-id pub-id-type="pmid">21146447</pub-id></citation></ref>
<ref id="B59"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jay</surname> <given-names>T. B.</given-names></name></person-group> (<year>1981</year>). <article-title>Computerphobia: what to do about it</article-title>. <source>Educ. Technol.</source> <volume>21</volume>, <fpage>47</fpage>&#x02013;<lpage>48</lpage>.</citation></ref>
<ref id="B30"><citation citation-type="confproc"><person-group person-group-type="author"><name><surname>Kahan</surname> <given-names>D. M.</given-names></name> <name><surname>Peters</surname> <given-names>E.</given-names></name> <name><surname>Dawson</surname> <given-names>E. C.</given-names></name> <name><surname>Slovic</surname> <given-names>P.</given-names></name></person-group> (<year>2013</year>). &#x0201C;<article-title>Motivated numeracy and enlightened self-government</article-title>,&#x0201D; in <conf-name>Yale Law School Public Law Working Paper 307</conf-name> <conf-loc>(New Haven, CT)</conf-loc>.</citation></ref>
<ref id="B31"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Kahneman</surname> <given-names>D.</given-names></name></person-group> (<year>2000</year>). &#x0201C;<article-title>Evaluation by moments: past and future</article-title>,&#x0201D; in <source>Choices, Values and Frames</source>, eds <person-group person-group-type="editor"><name><surname>Kahneman</surname> <given-names>D.</given-names></name> <name><surname>Tversky</surname> <given-names>A.</given-names></name></person-group> (<publisher-loc>New York, NY</publisher-loc>: <publisher-name>Cambridge University Press and Russell Sage Foundation</publisher-name>), <fpage>693</fpage>&#x02013;<lpage>708</lpage>.</citation></ref>
<ref id="B32"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kahneman</surname> <given-names>D.</given-names></name> <name><surname>Knetsch</surname> <given-names>J. L.</given-names></name></person-group> (<year>1992</year>). <article-title>Valuing public goods: the purchase of moral satisfaction</article-title>. <source>J. Environ. Econ. Manage.</source> <volume>22</volume>, <fpage>57</fpage>&#x02013;<lpage>70</lpage>. <pub-id pub-id-type="doi">10.1016/0095-0696(92)90019-s</pub-id></citation></ref>
<ref id="B33"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kahneman</surname> <given-names>D.</given-names></name> <name><surname>Knetsch</surname> <given-names>J. L.</given-names></name> <name><surname>Thaler</surname> <given-names>R. H.</given-names></name></person-group> (<year>1991</year>). <article-title>Anomalies: the endowment effect, loss aversion and status-quo bias</article-title>. <source>J. Econ. Perspect.</source> <volume>5</volume>, <fpage>193</fpage>&#x02013;<lpage>206</lpage>. <pub-id pub-id-type="doi">10.1257/jep.5.1.193</pub-id></citation></ref>
<ref id="B34"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kahneman</surname> <given-names>D.</given-names></name> <name><surname>Tversky</surname> <given-names>A.</given-names></name></person-group> (<year>1984</year>). <article-title>Choices, values and frames</article-title>. <source>Am. Psychol.</source> <volume>39</volume>, <fpage>341</fpage>&#x02013;<lpage>350</lpage>. <pub-id pub-id-type="doi">10.1037//0003-066x.39.4.341</pub-id></citation></ref>
<ref id="B35"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>King</surname> <given-names>S.</given-names></name> <name><surname>Griffin</surname> <given-names>S.</given-names></name> <name><surname>Hodges</surname> <given-names>Z.</given-names></name> <name><surname>Weatherly</surname> <given-names>H.</given-names></name> <name><surname>Asseburg</surname> <given-names>C.</given-names></name> <name><surname>Richardson</surname> <given-names>G.</given-names></name> <etal/></person-group>. (<year>2006</year>). <article-title>A systematic review and economic model of the effectiveness and cost-effectiveness of methylphenidate, dexamfetamine and atomoxetine for the treatment of attention deficit hyperactivity disorder in children and adolescents</article-title>. <source>Health Technol. Assess.</source> <volume>10</volume>, <fpage>iii</fpage>&#x02013;<lpage>iv</lpage>, <fpage>xiii</fpage>&#x02013;<lpage>146</lpage>. <pub-id pub-id-type="doi">10.3310/hta10230</pub-id><pub-id pub-id-type="pmid">16796929</pub-id></citation></ref>
<ref id="B36"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kunda</surname> <given-names>Z.</given-names></name></person-group> (<year>1990</year>). <article-title>The case for motivated reasoning</article-title>. <source>Psychol. Bull.</source> <volume>108</volume>, <fpage>480</fpage>&#x02013;<lpage>498</lpage>. <pub-id pub-id-type="doi">10.1037//0033-2909.108.3.480</pub-id><pub-id pub-id-type="pmid">2270237</pub-id></citation></ref>
<ref id="B37"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Larrick</surname> <given-names>R. P.</given-names></name></person-group> (<year>2004</year>). &#x0201C;<article-title>Debiasing</article-title>,&#x0201D; in <source>Blackwell Handbook of Judgment and Decision Making</source>, eds <person-group person-group-type="editor"><name><surname>Koehler</surname> <given-names>J.</given-names></name> <name><surname>Harvey</surname> <given-names>N.</given-names></name></person-group> (<publisher-loc>Malden, MA</publisher-loc>: <publisher-name>Blackwell</publisher-name>), <fpage>316</fpage>&#x02013;<lpage>337</lpage>.</citation></ref>
<ref id="B38"><citation citation-type="web"><person-group person-group-type="author"><name><surname>Mahdawi</surname> <given-names>A.</given-names></name></person-group> (<year>2012</year>). &#x0201C;<article-title>Speed and the city: meet the Adderall-addled adults of New York</article-title>,&#x0201D; in <source>The Guardian</source>. Available online at: <ext-link ext-link-type="uri" xlink:href="http://www.theguardian.com/commentisfree/2012/oct/12/adderall-new-york-capitalism">http://www.theguardian.com/commentisfree/2012/oct/12/adderall-new-york-capitalism</ext-link>. Accessed on October 12, 2012.</citation></ref>
<ref id="B39"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Maslen</surname> <given-names>H.</given-names></name> <name><surname>Faulm&#x000FC;ller</surname> <given-names>N.</given-names></name> <name><surname>Savulescu</surname> <given-names>J.</given-names></name></person-group> (<year>2014</year>). <article-title>Pharmacological cognitive enhancement&#x02014;how future neuroscientific research could advance ethical debate</article-title>. <source>Front. Syst. Neurosci.</source> <volume>8</volume>:<fpage>107</fpage>. <pub-id pub-id-type="doi">10.3389/fnsys.2014.00107</pub-id><pub-id pub-id-type="pmid"> 24999320</pub-id></citation></ref>
<ref id="B40"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Maslen</surname> <given-names>H.</given-names></name> <name><surname>Santoni de Sio</surname> <given-names>F.</given-names></name> <name><surname>Faulm&#x000FC;ller</surname> <given-names>N.</given-names></name></person-group> (<year>in press</year>). &#x0201C;<article-title>With cognitive enhancement comes great responsibility?</article-title>,&#x0201D; in <source>Responsible Innovation</source> (Vol. 2), eds <person-group person-group-type="editor"><name><surname>Koops</surname> <given-names>B. J.</given-names></name></person-group> (<publisher-loc>Dordrecht</publisher-loc>: <publisher-name>Springer</publisher-name>).</citation></ref>
<ref id="B41"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Partridge</surname> <given-names>B.</given-names></name> <name><surname>Bell</surname> <given-names>S.</given-names></name> <name><surname>Lucke</surname> <given-names>J.</given-names></name> <name><surname>Hall</surname> <given-names>W.</given-names></name></person-group> (<year>2013</year>). <article-title>Australian university students&#x02019; attitudes towards the use of prescription stimulants as cognitive enhancers: perceived patterns of use, efficacy and safety</article-title>. <source>Drug Alcohol Rev.</source> <volume>32</volume>, <fpage>295</fpage>&#x02013;<lpage>302</lpage>. <pub-id pub-id-type="doi">10.1111/dar.12005</pub-id><pub-id pub-id-type="pmid">23121045</pub-id></citation></ref>
<ref id="B42"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Repantis</surname> <given-names>D.</given-names></name> <name><surname>Schlattmann</surname> <given-names>P.</given-names></name> <name><surname>Laisney</surname> <given-names>O.</given-names></name> <name><surname>Heuser</surname> <given-names>I.</given-names></name></person-group> (<year>2010</year>). <article-title>Modafinil and methylphenidate for neuroenhancement in healthy individuals: a systematic review</article-title>. <source>Pharmacol. Res. </source> <volume>62</volume>, <fpage>187</fpage>&#x02013;<lpage>206</lpage>. <pub-id pub-id-type="doi">10.1016/j.phrs.2010.04.002</pub-id><pub-id pub-id-type="pmid">20416377</pub-id></citation></ref>
<ref id="B43"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ritov</surname> <given-names>I.</given-names></name> <name><surname>Baron</surname> <given-names>J.</given-names></name></person-group> (<year>1990</year>). <article-title>Reluctance to vaccinate: omission bias and ambiguity</article-title>. <source>J. Behav. Decis. Mak.</source> <volume>3</volume>, <fpage>263</fpage>&#x02013;<lpage>277</lpage>. <pub-id pub-id-type="doi">10.1002/bdm.3960030404</pub-id></citation></ref>
<ref id="B44"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Samuelson</surname> <given-names>W.</given-names></name> <name><surname>Zeckhauser</surname> <given-names>R.</given-names></name></person-group> (<year>1988</year>). <article-title>Status quo bias in decision making</article-title>. <source>J. Risk Uncertain.</source> <volume>1</volume>, <fpage>7</fpage>&#x02013;<lpage>59</lpage>. <pub-id pub-id-type="doi">10.1007/bf00055564</pub-id></citation></ref>
<ref id="B45"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sandel</surname> <given-names>M. J.</given-names></name></person-group> (<year>2004</year>). <article-title>The case against perfection: what&#x02019;s wrong with designer children, bionic athletes and genetic engineering</article-title>. <source>Atl. Mon.</source> <volume>292</volume>, <fpage>50</fpage>&#x02013;<lpage>54</lpage>, <fpage>56</fpage>&#x02013;<lpage>60</lpage>, <fpage>62</fpage>. <pub-id pub-id-type="pmid">15468473</pub-id></citation></ref>
<ref id="B46"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Savulescu</surname> <given-names>J.</given-names></name></person-group> (<year>2006</year>). &#x0201C;<article-title>Justice, fairness and enhancement</article-title>,&#x0201D; in <source>Progress in Convergence: Technologies for Human Wellbeing</source>, eds <person-group person-group-type="editor"><name><surname>Bainbridge</surname> <given-names>W. S.</given-names></name> <name><surname>Roco</surname> <given-names>M. C.</given-names></name></person-group> (<publisher-loc>Danvers, MA</publisher-loc>: <publisher-name>Wiley-Blackwell</publisher-name>), <fpage>321</fpage>&#x02013;<lpage>338</lpage>.</citation></ref>
<ref id="B47"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Savulescu</surname> <given-names>J.</given-names></name></person-group> (<year>2007</year>). &#x0201C;<article-title>Genetic interventions and the ethics of enhancement of human beings</article-title>,&#x0201D; in <source>The Oxford Handbook of Bioethics</source>, ed <person-group person-group-type="editor"><name><surname>Steinbock</surname> <given-names>B.</given-names></name></person-group> (<publisher-loc>Oxford</publisher-loc>: <publisher-name>Oxford University Press</publisher-name>), <fpage>516</fpage>&#x02013;<lpage>535</lpage>. <pub-id pub-id-type="doi">10.1093/oxfordhb/9780199562411.003.0023</pub-id></citation></ref>
<ref id="B48"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schelle</surname> <given-names>K. J.</given-names></name> <name><surname>Faulm&#x000FC;ller</surname> <given-names>N.</given-names></name> <name><surname>Caviola</surname> <given-names>L.</given-names></name> <name><surname>Hewstone</surname> <given-names>M.</given-names></name></person-group> (<year>2014</year>). <article-title>Attitudes toward pharmacological cognitive enhancement&#x02014;a review</article-title>. <source>Front. Syst. Neurosci.</source> <volume>8</volume>:<fpage>53</fpage>. <pub-id pub-id-type="doi">10.3389/fnsys.2014.00053</pub-id><pub-id pub-id-type="pmid">24860438</pub-id></citation></ref>
<ref id="B49"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Scheske</surname> <given-names>C.</given-names></name> <name><surname>Schnall</surname> <given-names>S.</given-names></name></person-group> (<year>2012</year>). <article-title>The ethics of &#x02018;Smart Drugs&#x02019;: moral judgments about healthy people&#x02019;s use of cognitive-enhancing drugs</article-title>. <source>Basic Appl. Soc. Psychol.</source> <volume>34</volume>, <fpage>508</fpage>&#x02013;<lpage>515</lpage>. <pub-id pub-id-type="doi">10.1080/01973533.2012.711692</pub-id></citation></ref>
<ref id="B50"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname> <given-names>M. E.</given-names></name> <name><surname>Farah</surname> <given-names>M. J.</given-names></name></person-group> (<year>2011</year>). <article-title>Are prescription stimulants &#x0201C;smart pills&#x0201D;? The epidemiology and cognitive neuroscience of prescription stimulant use by normal healthy individuals</article-title>. <source>Psychol. Bull.</source> <volume>137</volume>, <fpage>717</fpage>&#x02013;<lpage>741</lpage>. <pub-id pub-id-type="doi">10.1037/a0023825</pub-id><pub-id pub-id-type="pmid">21859174</pub-id></citation></ref>
<ref id="B51"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Spranca</surname> <given-names>M.</given-names></name> <name><surname>Minsk</surname> <given-names>E.</given-names></name> <name><surname>Baron</surname> <given-names>J.</given-names></name></person-group> (<year>1991</year>). <article-title>Omission and commission in judgment and choice</article-title>. <source>J. Exp. Soc. Psychol.</source> <volume>27</volume>, <fpage>76</fpage>&#x02013;<lpage>105</lpage>. <pub-id pub-id-type="doi">10.1016/0022-1031(91)90011-t</pub-id></citation></ref>
<ref id="B52"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Stanovich</surname> <given-names>K. E.</given-names></name></person-group> (<year>2004</year>). <source>The Robot&#x02019;s Rebellion. Finding Meaning in the Age of Darwin.</source> <publisher-loc>Chicago</publisher-loc>: <publisher-name>Chicago University Press</publisher-name>.</citation></ref>
<ref id="B54"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tversky</surname> <given-names>A.</given-names></name> <name><surname>Kahneman</surname> <given-names>D.</given-names></name></person-group> (<year>1974</year>). <article-title>Judgment under uncertainty&#x02014;heuristics and biases</article-title>. <source>Science</source> <volume>185</volume>, <fpage>1124</fpage>&#x02013;<lpage>1131</lpage>. <pub-id pub-id-type="doi">10.1126/science.185.4157.1124</pub-id><pub-id pub-id-type="pmid">17835457</pub-id></citation></ref>
<ref id="B55"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Urban</surname> <given-names>K. R.</given-names></name> <name><surname>Gao</surname> <given-names>W.-J.</given-names></name></person-group> (<year>2014</year>). <article-title>Performance enhancement at the cost of potential brain plasticity: neural ramifications of nootropic drugs in the healthy developing brain</article-title>. <source>Front. Syst. Neurosci.</source> <volume>8</volume>:<fpage>38</fpage>. <pub-id pub-id-type="doi">10.3389/fnsys.2014.00038</pub-id><pub-id pub-id-type="pmid">24860437</pub-id></citation></ref>
<ref id="B56"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Weil</surname> <given-names>M. M.</given-names></name> <name><surname>Rosen</surname> <given-names>L. D.</given-names></name></person-group> (<year>1995</year>). <article-title>The psychological impact of technology from a global perspective: a study of technological sophistication and technophobia in university students from twenty-three countries</article-title>. <source>Comput. Hum. Behav.</source> <volume>11</volume>, <fpage>95</fpage>&#x02013;<lpage>133</lpage>. <pub-id pub-id-type="doi">10.1016/0747-5632(94)00026-e</pub-id></citation></ref>
<ref id="B57"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Weinberg</surname> <given-names>B. A.</given-names></name> <name><surname>Bealer</surname> <given-names>B. K.</given-names></name></person-group> (<year>2001</year>). <source>The World of Caffeine: The Science and Culture of the World&#x02019;s Most Popular Drug.</source> <publisher-loc>New York, NY</publisher-loc>: <publisher-name>Routledge</publisher-name>.</citation></ref>
<ref id="B58"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Weinstein</surname> <given-names>N. D.</given-names></name> <name><surname>Klein</surname> <given-names>W. M.</given-names></name></person-group> (<year>1996</year>). <article-title>Unrealistic optimism: present and future</article-title>. <source>J. Soc. Clin. Psychol.</source> <volume>15</volume>, <fpage>1</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1521/jscp.1996.15.1.1</pub-id></citation></ref>
</ref-list>
</back>
</article>